Clinical Trials
3 trialsNCT04869488 2025-01-24
A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT04535687 2023-06-13
Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Completed
NCT02747342 2020-07-21
A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer
Atridia Pty Ltd.
Phase 1 Completed